UNCONVENTIONAL PATTERN OF RESPONSE IN A METASTATIC MELANOMA PATIENT TREATED WITH IPILIMUMAB.

by Francesco Spagnolo
Published 2012-03-01

MALIGNANT MELANOMA ARISING IN A SPECKLED LENTIGINOUS NEVUS.

by Francesco Spagnolo
Published 2012-01-01

ELEVATED SERUM S-100B LEVELS WITH NEGATIVE PET/TC AND CT-SCAN IN A METASTATIC MELANOMA PATIENT.

by Francesco Spagnolo
Published 2012-01-01

COMPLETE RESPONSE OF CUTANEOUS METASTASIS IN A MELANOMA PATIENT TREATED WITH IPILIMUMAB.

by Francesco Spagnolo, Serena Savaia, Marco Grosso, Paola Queirolo
Published 2012-01-01

Treatment beyond progression with anti-PD-1/PD-L1 based regimens in advanced solid tumors: a systematic review

by Francesco Spagnolo, Andrea Boutros, Federica Cecchi, Elena Croce, Enrica Teresa Tanda, Paola Queirolo
Published 2021-04-01

Regenerative Surgery for the Definitive Repair of a Vasculitic Nonhealing Ulcer Using Platelet-derived Growth Factors and Noncultured Autologous Cell Suspension

by Maria Trapasso, MD, Francesco Spagnolo, MD, Filippo Marchi, MD, Paolo Strada, MD, Pierluigi Santi, MD, Marco Scala, MD
Published 2013-05-01

Patients with locally advanced and metastatic cutaneous squamous cell carcinoma treated with immunotherapy in the era of COVID-19: stop or go? Data from five Italian referral cance...

by Maristella Saponara, Laura Pala, Fabio Conforti, Marco Rubatto, Ivana De Risi, Francesco Spagnolo, Michele Guida, Paolo Bossi, Pietro Quaglino, Paola Queirolo
Published 2020-11-01

Case Report: Immune-Related Toxicity During Adjuvant Treatment With BRAF Plus MEK Inhibitors in a Melanoma Patient

by Andrea Boutros, Andrea Boutros, Chiara Schiavi, Federica Cecchi, Francesco Spagnolo, Antonio Guadagno, Enrica Teresa Tanda, Francesca Giusti, Giuseppe Murdaca, Paola Queirolo
Published 2020-11-01

The Current State of Molecular Testing in the BRAF-Mutated Melanoma Landscape

by Irene Vanni, Irene Vanni, Enrica Teresa Tanda, Francesco Spagnolo, Virginia Andreotti, Virginia Andreotti, William Bruno, William Bruno, Paola Ghiorzo, Paola Ghiorzo
Published 2020-06-01

How to Make Immunotherapy an Effective Therapeutic Choice for Uveal Melanoma

by Mariarosaria Marseglia, Adriana Amaro, Nicola Solari, Rosaria Gangemi, Elena Croce, Enrica Teresa Tanda, Francesco Spagnolo, Gilberto Filaci, Ulrich Pfeffer, Michela Croce
Published 2021-04-01

Efficacy of BRAF and MEK Inhibition in Patients with BRAF-Mutant Advanced Melanoma and Germline CDKN2A Pathogenic Variants

by Francesco Spagnolo, Bruna Dalmasso, Enrica Tanda, Miriam Potrony, Susana Puig, Remco van Doorn, Ellen Kapiteijn, Paola Queirolo, Hildur Helgadottir, Paola Ghiorzo
Published 2021-05-01

Immunotherapy in Adolescents and Young Adults: What Remains in Cancer Survivors?

by Enrica Teresa Tanda, Enrica Teresa Tanda, Elena Croce, Francesco Spagnolo, Lodovica Zullo, Stefano Spinaci, Carlo Genova, Carlo Genova, Giovanni Rossi, Giovanni Rossi
Published 2021-09-01

Current State of Target Treatment in BRAF Mutated Melanoma

by Enrica Teresa Tanda, Irene Vanni, Irene Vanni, Andrea Boutros, Virginia Andreotti, Virginia Andreotti, William Bruno, William Bruno, Paola Ghiorzo, Paola Ghiorzo, Francesco Spagnolo
Published 2020-07-01

Effect of Age on Melanoma Risk, Prognosis and Treatment Response

by Simone Ribero, Luigia Stefania Stucci, Elena Marra, Riccardo Marconcini, Francesco Spagnolo, Laura Orgiano, Virginia Picasso, Paola Queirolo, Guiseppe Palmieri, Pietro Quaglino, Veronique Bataille
Published 2018-05-01

Immunotherapy for the Treatment of Cutaneous Squamous Cell Carcinoma

by Andrea Boutros, Andrea Boutros, Federica Cecchi, Enrica Teresa Tanda, Enrica Teresa Tanda, Elena Croce, Elena Croce, Riccardo Gili, Riccardo Gili, Luca Arecco, Luca Arecco, Francesco Spagnolo, Paola Queirolo
Published 2021-08-01

Non-BRAF Mutant Melanoma: Molecular Features and Therapeutical Implications

by Irene Vanni, Irene Vanni, Enrica Teresa Tanda, Bruna Dalmasso, Bruna Dalmasso, Lorenza Pastorino, Lorenza Pastorino, Virginia Andreotti, Virginia Andreotti, William Bruno, William Bruno, Andrea Boutros, Francesco Spagnolo, Paola Ghiorzo, Paola Ghiorzo
Published 2020-07-01

Merkel Cell Carcinoma: An Immunotherapy Fairy-Tale?

by Enrica Teresa Tanda, Enrica Teresa Tanda, Agostina Lagodin d’Amato, Agostina Lagodin d’Amato, Giovanni Rossi, Giovanni Rossi, Elena Croce, Elena Croce, Andrea Boutros, Andrea Boutros, Federica Cecchi, Francesco Spagnolo, Paola Queirolo
Published 2021-09-01

Clinical, pathological and dermoscopic phenotype of MITF p.E318K carrier cutaneous melanoma patients

by Giulia Ciccarese, Bruna Dalmasso, William Bruno, Paola Queirolo, Lorenza Pastorino, Virginia Andreotti, Francesco Spagnolo, Enrica Tanda, Giovanni Ponti, Cesare Massone, Francesco Drago, Aurora Parodi, Giovanni Ghigliotti, Maria Antonietta Pizzichetta, Paola Ghiorzo, Italian Melanoma Intergroup (I.M.I.)
Published 2020-02-01

No Impact of NRAS Mutation on Features of Primary and Metastatic Melanoma or on Outcomes of Checkpoint Inhibitor Immunotherapy: An Italian Melanoma Intergroup (IMI) Study

by Michele Guida, Nicola Bartolomeo, Pietro Quaglino, Gabriele Madonna, Jacopo Pigozzo, Anna M. Di Giacomo, Alessandro M. Minisini, Marco Tucci, Francesco Spagnolo, Marcella Occelli, Laura Ridolfi, Paola Queirolo, Ivana De Risi, Davide Quaresmini, Elisabetta Gambale, Vanna Chiaron Sileni, Paolo A. Ascierto, Lucia Stigliano, Sabino Strippoli, on behalf of the Italian Melanoma Intergroup (IMI) Study
Published 2021-01-01

Insights into Genetic Susceptibility to Melanoma by Gene Panel Testing: Potential Pathogenic Variants in ACD, <i>ATM, BAP1,</i> and <i>POT1</i>

by Lorenza Pastorino, Virginia Andreotti, Bruna Dalmasso, Irene Vanni, Giulia Ciccarese, Mario Mandalà, Giuseppe Spadola, Maria Antonietta Pizzichetta, Giovanni Ponti, Maria Grazia Tibiletti, Elena Sala, Maurizio Genuardi, Pietro Chiurazzi, Gabriele Maccanti, Siranoush Manoukian, Serena Sestini, Rita Danesi, Valentina Zampiga, Roberta La Starza, Ignazio Stanganelli, Alberto Ballestrero, Luca Mastracci, Federica Grillo, Stefania Sciallero, Federica Cecchi, Enrica Teresa Tanda, Francesco Spagnolo, Paola Queirolo, Italian Melanoma Intergroup (IMI), Alisa M. Goldstein, William Bruno, Paola Ghiorzo
Published 2020-04-01